Shopping Cart
- Remove All
- Your shopping cart is currently empty
PF-06647263 (anti-EFNA4-ADC) is an SDC compound targeting EFNA4-ADC, with anti-tumor activity, composed of an anti-EFNA4 antibody conjugated with calicheamicin, inducing significant tumor regression in TNBC xenografts.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 424 € | In Stock | |
5 mg | 1.330 € | In Stock | |
10 mg | 2.128 € | In Stock | |
25 mg | 3.999 € | In Stock |
Description | PF-06647263 (anti-EFNA4-ADC) is an SDC compound targeting EFNA4-ADC, with anti-tumor activity, composed of an anti-EFNA4 antibody conjugated with calicheamicin, inducing significant tumor regression in TNBC xenografts. |
Targets&IC50 | 293T-EFNA4 cell:1 ng/mL (EC50) |
In vitro | PF-06647263 induces antigenic and concentration-dependent cytotoxicity, and exposure to PF-06647263 for 96 hours causes 293T-EFNA4 cell death (EC50 ≈ 1 ng/mL). [1] |
In vivo | In mice with a breast PDX tumor model, 0.27 mg/kg PF-06647263 resulted in significant tumor regression. [1] |
Alias | PF06647263, anti-EFNA4-ADC |
Molecular Weight | 145.5 kDa |
Cas No. | 1822383-65-2 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.